EPISODE · May 13, 2022 · 22 MIN
Fraud and Abuse: Recent Changes to PhRMA’s Code Related to Speaker Programs
from AHLA's Speaking of Health Law · host AHLA Podcasts
In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks with Julie Wagner, Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA, and Martina Rozumberkova, Principal, Control Risks, about changes made to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code related to speaker programs, partly in response to 2020 guidance from HHS’ Office of Inspector General. They discuss PhRMA’s process for making the changes, what compliance officers need to know about the changes, and PhRMA’s role in the debate about the provision of meals. From AHLA's Fraud and Abuse Practice Group. Sponsored by BRG.Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.
What this episode covers
In this episode of AHLA's monthly series on fraud and abuse issues, Matthew Wetzel, Partner, Goodwin Procter, speaks with Julie Wagner, Head of Global Ethics, Compliance & Enforcement Legal Policy, PhRMA, and Martina Rozumberkova, Principal, Control Risks, about changes made to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code related to speaker programs, partly in response to 2020 guidance from HHS’ Office of Inspector General. They discuss PhRMA’s process for making ...
NOW PLAYING
Fraud and Abuse: Recent Changes to PhRMA’s Code Related to Speaker Programs
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m